MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.675
-0.002 (-0.33%)
Oct 10, 2024, 11:50 AM EDT - Market open

MiNK Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-17.09-22.46-27.99-30.21-16.24-23.8
Depreciation & Amortization
0.210.20.120.080.060.04
Stock-Based Compensation
3.073.863.031.740.090.22
Other Operating Activities
0.2-0.27-2.7911.836.281.05
Change in Accounts Payable
-1.66-1.922.66-0.150.610.89
Change in Unearned Revenue
-----0.190.19
Change in Other Net Operating Assets
3.384.816.113.891.066.47
Operating Cash Flow
-12.08-15.76-18.87-12.83-8.34-14.94
Capital Expenditures
-0.02-0.07-0.25-0.25-0.1-0.43
Investing Cash Flow
-0.02-0.07-0.25-0.25-0.1-0.43
Long-Term Debt Issued
---9.4611.1111.44
Net Debt Issued (Repaid)
5--9.4611.1111.44
Issuance of Common Stock
5.820.070460-
Repurchase of Common Stock
--0.48-0.16---
Other Financing Activities
----6.2--
Financing Cash Flow
10.82-0.41-0.1649.2611.1111.44
Foreign Exchange Rate Adjustments
-0.02-0.030.020.02-0.28-0.12
Net Cash Flow
-1.31-16.27-19.2536.22.39-4.06
Free Cash Flow
-12.1-15.84-19.12-13.08-8.43-15.37
Free Cash Flow Margin
------2228.86%
Free Cash Flow Per Share
-0.34-0.46-0.57-0.50-0.35-0.64
Cash Interest Paid
0.020.030.01---
Levered Free Cash Flow
-8.16-11.08-20.25-8.67-2.21-
Unlevered Free Cash Flow
-8.16-11.08-20.25-7.15-0.68-
Change in Net Working Capital
1.050.743.8-2.9-6.02-
Source: S&P Capital IQ. Standard template. Financial Sources.